thyroid issues with glp 1 The Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care Should Patients With Thyroid Issues

It has never been approved, so it cannot be in "shortage," so there is no legal basis for compounding

Related products Select options This product has multiple variants

GLP-1

The most frequent issues reported from the phase 3 studies are nausea (19%), fatigue (6%), skin darkening (4%), dizziness (4%), and the development of moles (4%)

However, concerns post-treatment are typically minimal, and patients can carry on with their normal activities uninterrupted

Kenvue has stated it intends to again challenge the reliability of the plaintiffs' expert testimony under Daubert standards, the legal framework courts use to evaluate the scientific basis of expert opinion